Skip to main content
healthportal
SubscribeβŠ™Sign in
πŸ”12+ medical reviewers in networkπŸ†FDA & peer-reviewed sourcesπŸ“ˆUpdated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signupΒ· 5,400+ readers Β· weekly Β· unsubscribe anytime

healthportal

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspaΓ±ol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. Β© 2026 Health Portal.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeGLP-1 switching guide

Switching between medications

GLP-1 switching guide

Switching between GLP-1 medications is rarely a 1:1 dose swap. Same-ingredient switches (Ozempic ↔ Wegovy, Mounjaro ↔ Zepbound) usually preserve your current dose. Cross-ingredient switches (semaglutide ↔ tirzepatide) require re-titration. Below are 12 directional guides covering FDA-label dose conversion, side-effect transitions, and insurance considerations.

  • Reviewed against FDA labels
  • 12 directional guides

Pick your switch direction

Switching from→ Ozempic→ Wegovy→ Mounjaro→ Zepbound
Ozempicβ€”Guide Guide Guide
WegovyGuide β€”Guide Guide
MounjaroGuide Guide β€”Guide
ZepboundGuide Guide Guide β€”

All 12 switching guides

OzempicWegovy

semaglutide

Same drug (semaglutide), different FDA indication β€” for patients who want weight-loss coverage.

Same active ingredient
WegovyOzempic

semaglutide

Same drug, different label β€” usually a cost / insurance driver, not a clinical one.

Same active ingredient
MounjaroZepbound

tirzepatide

Same drug (tirzepatide), Zepbound is the weight-loss-labeled version.

Same active ingredient
ZepboundMounjaro

tirzepatide

Same drug, switch when diabetes diagnosis becomes the primary indication.

Same active ingredient
OzempicMounjaro

semaglutide β†’ tirzepatide

Type 2 diabetes patients switching from semaglutide to tirzepatide for stronger glycemic control.

Cross-ingredient (re-titrate)
MounjaroOzempic

tirzepatide β†’ semaglutide

Reverse switch β€” usually for insurance, side-effect tolerance, or shortage reasons.

Cross-ingredient (re-titrate)
WegovyZepbound

semaglutide β†’ tirzepatide

Semaglutide β†’ tirzepatide for weight loss β€” strongest head-to-head data favors tirzepatide.

Cross-ingredient (re-titrate)
ZepboundWegovy

tirzepatide β†’ semaglutide

Tirzepatide β†’ semaglutide β€” typically insurance, side effects, or cost-driven.

Cross-ingredient (re-titrate)
OzempicZepbound

semaglutide β†’ tirzepatide

Cross-class switch β€” same patient often wants weight-loss-labeled drug with stronger effect.

Cross-ingredient (re-titrate)
WegovyMounjaro

semaglutide β†’ tirzepatide

Patient developed type 2 diabetes β€” switch from weight-loss-labeled to diabetes-labeled tirzepatide.

Cross-ingredient (re-titrate)
MounjaroWegovy

tirzepatide β†’ semaglutide

Tirzepatide β†’ semaglutide for weight loss specifically β€” insurance or formulary driven.

Cross-ingredient (re-titrate)
ZepboundOzempic

tirzepatide β†’ semaglutide

Cross-class reverse β€” usually diabetes diagnosis appears and weight-loss coverage drops.

Cross-ingredient (re-titrate)

Switching needs prescriber approval

Never switch GLP-1 medications without a prescriber visit. Your provider confirms the indication, writes the new prescription, manages insurance prior authorization, and documents the titration schedule. These guides are educational reference β€” not a substitute for medical evaluation.

Ready to switch?

Most telehealth providers handle switching prescriptions in 1–3 business days. The ranked providers below process prior authorizations and coordinate with the destination pharmacy.

See top providers for 2026